/PRNewswire/ - The global nuclear medicine market size is expected to reach USD 22.3 billion by 2030, registering a CAGR of 11.8% over the forecast period,.
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Personnel
Reorganization in the Executive Board of Eckert &. | May 15, 2023
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor in encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendations owing to no proven significant adve.
U.S. FDA granted Fast Track designation for 177Lu-PNT2002 for the treatment of mCRPC in April 2023 Announces $10 million strategic investment in commercial-scale alpha-emitting isotope manufacturer,. | May 15, 2023
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Quarter Results
Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
11.05.2023 /. | May 11, 2023